<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatrician (St. Petersburg)</journal-id><journal-title-group><journal-title xml:lang="en">Pediatrician (St. Petersburg)</journal-title><trans-title-group xml:lang="ru"><trans-title>Педиатр</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-7850</issn><issn publication-format="electronic">2587-6252</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11226</article-id><article-id pub-id-type="doi">10.17816/PED9663-72</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The foci of aberrant crypts and changes of microbiota of gut upon chemical mutagenesis and experimental hyperand hypothyroid status</article-title><trans-title-group xml:lang="ru"><trans-title>Фокусы аберрантных крипт и изменения микробиоты кишечника на фоне химического мутагенеза и экспериментального гипери гипотиреоза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Proshin</surname><given-names>Sergei N.</given-names></name><name xml:lang="ru"><surname>Прошин</surname><given-names>Сергей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Dr Med Sci, Professor, Head, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующий, кафедра фармакологии</p></bio><email>psnjsn@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kurbanov</surname><given-names>Ruslan A.</given-names></name><name xml:lang="ru"><surname>Курбанов</surname><given-names>Руслан Абдулрашидович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student, Department of Operative Surgery and Topographic Anatomy</p></bio><bio xml:lang="ru"><p>аспирант, кафедра оперативной хирургии и топографической анатомии</p></bio><email>ruslan_kra@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Loskutov</surname><given-names>Svyatoslav I.</given-names></name><name xml:lang="ru"><surname>Лоскутов</surname><given-names>Святослав Игоревич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>General Director</p></bio><bio xml:lang="ru"><p>генеральный директор</p></bio><email>info@bioecotech.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barsukov</surname><given-names>Nikita N.</given-names></name><name xml:lang="ru"><surname>Барсуков</surname><given-names>Никита Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Staff, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>лаборант, кафедра фармакологии</p></bio><email>nikich.spn@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alibekov</surname><given-names>Hajimurad O.</given-names></name><name xml:lang="ru"><surname>Алибеков</surname><given-names>Хаджимурад Омарович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Staff, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>лаборант, кафедра фармакологии</p></bio><email>Knowledge-7780@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kachanov</surname><given-names>Dmitrii A.</given-names></name><name xml:lang="ru"><surname>Качанов</surname><given-names>Дмитрий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Staff, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>лаборант, кафедра фармакологии</p></bio><email>kachanov.dima@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Glushakov</surname><given-names>Ruslan I.</given-names></name><name xml:lang="ru"><surname>Глушаков</surname><given-names>Руслан Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor, Department of Obstatrics and Gyneacology</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, кафедра акушерства и гинекологии</p></bio><email>glushakovruslan@gmail.com</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bagaturiya</surname><given-names>Georgii O.</given-names></name><name xml:lang="ru"><surname>Багатурия</surname><given-names>Георгий Отарович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Dr Med Sci, Professor, Head, Department of Operative surgery and topographic anatomy</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующий, кафедра оперативной хирургии и топографической анатомии</p></bio><email>geobag@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">North-Western State Medical University named after I.I. Mechnikov</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">St Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Limited Liability Company “Scientific production association “BioEcoTech”</institution></aff><aff><institution xml:lang="ru">ООО «НПО «БиоЭкоТех»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Military Medical Academy named after S.M. Kirov</institution></aff><aff><institution xml:lang="ru">ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Минобороны России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>9</volume><issue>6</issue><issue-title xml:lang="en">VOL 9, NO6 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 9, №6 (2018)</issue-title><fpage>63</fpage><lpage>72</lpage><history><date date-type="received" iso-8601-date="2019-02-26"><day>26</day><month>02</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Proshin S.N., Kurbanov R.A., Loskutov S.I., Barsukov N.N., Alibekov H.O., Kachanov D.A., Glushakov R.I., Bagaturiya G.O.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Прошин С.Н., Курбанов Р.А., Лоскутов С.И., Барсуков Н.Н., Алибеков Х.О., Качанов Д.А., Глушаков Р.И., Багатурия Г.О.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Proshin S.N., Kurbanov R.A., Loskutov S.I., Barsukov N.N., Alibekov H.O., Kachanov D.A., Glushakov R.I., Bagaturiya G.O.</copyright-holder><copyright-holder xml:lang="ru">Прошин С.Н., Курбанов Р.А., Лоскутов С.И., Барсуков Н.Н., Алибеков Х.О., Качанов Д.А., Глушаков Р.И., Багатурия Г.О.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/pediatr/article/view/11226">https://journals.eco-vector.com/pediatr/article/view/11226</self-uri><abstract xml:lang="en"><p>In our paper we present data on the induction of nitrosomethylurea focuses of aberrant crypts on experimentally altered thyroid status in mice and concomitant changes in the intestinal microbiota. Since the foci of aberrant crypts are an obvious prerequisite for long-range malignancy in colorectal cancer, the induction of colorectal cancer induced by nitrosomethylurea is the most appropriate model for investigating mechanisms of carcinogenesis. Male BALB / c male mice which were treated with nitrosomethylurea (NMU) for 24 weeks when also combined with L-thyroxin or propylthiouracil were used in the study. The results indicate that the incidence of aberrant crypt foci (FAC) was significantly higher for a group of animals which were treated with both NMU and L-thyroxin 38.9 ± 3.6%. At the same time the incidence of FAC with hyperthyroid status only without exposure to NMU was also high at 12.9 ± 4.2%. It was shown that the hypothyroid status had a significant protective effect on the intestinal epithelium when exposed to HMN – 16.1 ± 2.5%. A significant quantitative decrease in <italic>Lactobacillus spp</italic>. of microbiome was detected in groups of mice exposed not only to NMU, but also in animals with experimentally induced hyperthyroid status only. Mechanisms that contribute to the occurrence of an increased frequency of FAC in the context of hyper- and hypothyroid status are discussed. It was concluded that an increased incidence of foci of aberrant crypts and a decrease in the quantity of the normal microbiota are associated with hyperthyroid status which modulated upon administration of methylnitrosourea.</p></abstract><trans-abstract xml:lang="ru"><p>В статье представлены данные об индукции метилнитрозомочевиной фокусов аберрантных крипт на фоне экспериментально измененного тиреоидного статуса у мышей и сопутствующих изменений микробиоты кишечника. Так как фокусы аберрантных крипт служат очевидной предпосылкой для дальней малигнизации в колоректальный рак, то индукция колоректального рака метилнитрозомочевиной является наиболее приемлемой моделью для исследования механизмов канцерогенеза. В работе были использованы мыши-самцы линии BALB/c, которые получали метилнитрозомочевину (МНМ) при сочетанном воздействии L-тироксина или пропилтиоурацила в течение 24 недель. Результаты исследования указывают, что частота возникновения фокусов аберрантных крипт (ФАК) была достоверно выше для группы животных, которые получали как МНМ, так и L-тироксин (38,9 ± 3,6 %). При этом частота возникновения ФАК на фоне гипертиреоидного статуса без воздействия МНМ также находилась на высоком уровне (12,9 ± 4,2 %). При этом гипотиреоидный статус оказывал достоверно выраженное защитное влияние на эпителий кишечника при воздействии МНМ (16,1 ± 2,5 %). Обнаружено достоверное количественное снижение <italic>Lactobacillus spp</italic>. как в группах мышей, подвергавшихся воздействию МНМ, так и у животных на фоне гипертиреоидного статуса. Обсуждаются механизмы, способствующие возникновению повышенной частоты ФАК в контексте гипер- и гипотиреоидного статуса. Сделан вывод, что повышенная частота возникновения фокусов аберрантных крипт и снижение представителей нормальной микробиоты ассоциированы с гипертиреозом, который модулируется введением метилнитрозомочевины.</p></trans-abstract><kwd-group xml:lang="en"><kwd>nitrosomethylurea</kwd><kwd>hyper- and hypothyroid status</kwd><kwd>foci of aberrant crypts</kwd><kwd>microbiota of gut</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>метилнитрозомочевина</kwd><kwd>гипер- и гипотиреоз</kwd><kwd>фокусы аберрантных крипт</kwd><kwd>микробиота кишечника</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Власьева О.В., Глушаков Р.И., Соболев И.В., и др. Риск возникновения злокачественных новообразований у женщин с длительно протекающим гипертиреозом в анамнезе: ретроспективное рандомизированное исследование // Педиатр. - 2015. - Т. 6. - № 2. - С. 17-21. [Vlaseva OV, Glushakov RI, Sobolev IV, et al. The risk of malignancies in women with long flowing hyperthyroidism in history: a retrospective randomized study. Pediatrician (St. Petersburg). 2015;6(2):17-21. (In Russ.)]. doi: 10.17816/PED6217-21.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Глушаков Р.И., Власьева О.В., Соболев И.В., и др. Тиреоидный статус как прогностический маркер в онкологии // Педиатр. - 2015. - Т. 6. - № 3. - С. 112-117. [Glushakov RI, Vlaseva OV, Sobolev IV, et al. Thyroid status as prognostic marker in oncology. Pediatrician (St. Petersburg). 2015;6(3):112-117. (In Russ.)]. doi: 10.17816/PED63112-117.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Глушаков Р.И., Власьева О.В., Соболев И.В., и др. Стратегия фармакологической коррекции длительно протекающих негеномных эффектов тиреоидных гормонов // Обзоры по клинической фармакологии и лекарственной терапии. - 2015. - Т. 13. - № S1. - С. 48-49. [Glushakov RI, Vlas’eva OV, Sobolev IV, et al. Strategiya farmakologicheskoy korrektsii dlitel’no protekayushchikh negenomnykh effektov tireoidnykh gormonov. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2015;13(S1):48-49. (In Russ.)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Глушаков Р.И., Тапильская Н.И., Прошин С.Н. Частота возникновения опухоли молочной железы при индуцированном гипертиреозе в эксперименте // Бюллетень экспериментальной биологии и медицины. - 2013. - Т. 156. - №. 8. - С. 212-215. [Glushakov RI, Tapil’skaya NI, Proshin SN. Chastota vozniknoveniya opukholi molochnoy zhelezy pri indutsirovannom gipertireoze v eksperimente. Biull Eksp Biol Med. 2013;156(8):212-215. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Глушаков Р.И., Дробленков А.В., Тапильская Н.И., Прошин С.Н. Морфологические изменения молочной железы и яичников у мышей с экспериментально измененным тиреоидным статусом // Ученые записки СПбГМУ им. акад. И.П. Павлова. - 2014. - Т. 21. - № 1. - С. 81-87. [Glushakov RI, Droblenkov AV, Tapil’skaya NI, Proshin SN. Morphological changes in the breast gland and ovary of mice with experimentally induced hyperthyroid condition. Scientific notes of the I.P. Pavlov St. Petersburg State Medical University. 2014;21(1):81-87. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Голод Н.А., Лойко Н.Г., Мулюкин А.Л., и др. Адаптация молочнокислых бактерий к неблагоприятным для роста условиям // Микробиология. - 2009. - Т. 78. - № 3. - С. 317-335. [Golod NA, Loyko NG, Mulyukin AL, et al. Adaptatsiya molochnokislykh bakteriy k neblagopriyatnym dlya rosta usloviyam. Mikrobiologiia. 2009;78(3):317-335. (In Russ.)]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ипатова М.Г., Шумилов П.В., Мухина Ю.Г., и др. Дисрегуляция иммунного ответа на индигенную микрофлору у детей и подростков с воспалительными заболевания кишечника // Педиатрия. Журнал им. Г.Н. Сперанского. - 2010. - Т. 89. - № 2. - С. 45-49. [Ipatova MG, Shumilov PV, Mukhina YG, et al. Disregulyatsiya immunnogo otveta na indigennuyu mikrofloru u detey i podrostkov s vospalitel’nymi zabolevaniya kishechnika. Pediatriia. 2010;89(2):45-49. (In Russ.)]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Курбанов Р.А., Лапкина Г.Я., Багатурия Г.О., и др. Влияние медикаментозно измененного тиреоидного статуса на возникновение фокусов аберрантных крипт в слизистой прямой кишки, индуцированных нитрозометилмочевиной // Экспериментальная и клиническая фармакология. - 2018. - Т. 81. - № S. - С. 135. [Kurbanov RA, Lapkina GY, Bagaturiya GO, et al. Vliyanie medikamentozno izmenennogo tireoidnogo statusa na vozniknovenie fokusov aberrantnykh kript v slizistoy pryamoy kishki, indutsirovannykh nitrozometilmochevinoy. Eksp Klin Farmakol. 2018;81(S):135. (In Russ.)]. doi: 10.30906/0869-2092-2018-81-5s-1-306.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Стадников А.А., Бухарин О.В. Гипоталамическая нейросекреция и структурно-функциональный гомеостаз про- и эукариот (морфологические основы реактивности, пластичности, регенерации). - Оренбург: ОрГМА, 2012. [Stadnikov AA, Bukharin OV. Gipotalamicheskaya neyrosekretsiya i strukturno-funktsional’nyy gomeostaz pro- i eukariot (morfologicheskie osnovy reaktivnosti, plastichnosti, regeneratsii). Orenburg: OrGMA; 2012. (In Russ.)]</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Akgul H, Tez M, Unal AE, et al. Echinococcus against cancer: why not? Cancer. 2003;98(9):1999-2000. doi: 10.1002/cncr.11752.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Anderson JC, Swede H, Rustagi T, et al. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control. 2012;23(2):355-361. doi: 10.1007/s10552-011-9884-7.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bolognani F, Rumney CJ, Pool-Zobel BL, Rowland IR. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr. 2001;40(6):293-300. doi: 10.1007/s394-001-8359-7.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chen L, He Z, Qin L, et al. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS One. 2011;6(9):e24407. doi: 10.1371/journal.pone.0024407.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol. 2009;155(1):1-15. doi: 10.1111/j.1365-2249.2008.03834.x.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ferrandez A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol. 2004;99(10):2012-2018. doi: 10.1111/j.1572-0241.2004.30021.x.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ferrandez A, DiSario JA. Colorectal cancer: screening and surveillance for high-risk individuals. Expert Rev Anticancer Ther. 2003;3(6):851-862. doi: 10.1586/14737140.3.6.851.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Freudenheim JL, LaMonte MJ. Periodontal Disease and Breast Cancer-Response. Cancer Epidemiol Biomarkers Prev. 2016;25(5):864. doi: 10.1158/1055-9965.EPI-16-0076.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hellevik AI, Asvold BO, Bjoro T, et al. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev. 2009;18(2):570-574. doi: 10.1158/1055-9965.EPI-08-0911.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Huang R, Tao X, Wan C, et al. In vitro probiotic characteristics of Lactobacillus plantarum ZDY2013 and its modulatory effect on gut microbiota of mice. J Dairy Sci. 2015;98(9):5850-5861. doi: 10.3168/jds.2014-9153.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hunter CA, Yu D, Gee M, et al. Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J Immunol. 2001;166(10):5878-5881.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Jeter JM, Kohlmann W, Gruber SB. Genetics of colorectal cancer. Oncology (Williston Park). 2006;20(3):269-276; discussion 285-266, 288-269.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kaeid Sharaf L, Shukla G. Probiotics (Lactobacillus acidophilus and Lactobacillus rhamnosus GG) in Conjunction with Celecoxib (selective COX-2 inhibitor) Modulated DMH-Induced Early Experimental Colon Carcinogenesis. Nutr Cancer. 2018:1-10. doi: 10.1080/01635581.2018.1490783.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Klewicka E, Zdunczyk Z, Juskiewicz J, Klewicki R. Effects of Lactofermented Beetroot Juice Alone or with N-nitroso-N-methylurea on Selected Metabolic Parameters, Composition of the Microbiota Adhering to the Gut Epithelium and Antioxidant Status of Rats. Nutrients. 2015;7(7):5905-5915. doi: 10.3390/nu7075260.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Kurt A, Aygun AD, Sengul I, et al. Serum thyroid hormones levels are significantly decreased in septic neonates with poor outcome. J Endocrinol Invest. 2011;34(4):e92-96. doi: 10.3275/7261.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92(11):4180-4184. doi: 10.1210/jc.2007-0606.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661-672. doi: 10.1038/nrmicro3344.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Oliveira EC, Leite MS, Miranda JA, et al. Chronic Trypanosoma cruzi infection associated with low incidence of 1,2-dimethylhydrazine-induced colon cancer in rats. Carcinogenesis. 2001;22(5):737-740. doi: 10.1093/carcin/22.5.737.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Perse M, Cerar A. Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol. 2011;2011:473964. doi: 10.1155/2011/473964.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 1991;51(5):1564-1567.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ribichini D, Fiorini G, Repaci A, et al. Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection. Endocrine. 2017;57(3):394-401. doi: 10.1007/s12020-016-1167-3.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Roncucci L, Stamp D, Medline A, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22(3):287-294. doi: 10.1016/0046-8177(91)90163-J.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>da Silveira AB, Lemos EM, Adad SJ, et al. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol. 2007;38(8):1256-64. doi: 10.1016/j.humpath.2007.01.020.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Skorobogatykh II, Perunova NB, Kurlaev PP, Bukharin OV. Experimental study of combination of ciprofloxacin and oxytocin on formation of biofilms by opportunistic bacteria. Zh Mikrobiol Epidemiol Immunobiol. 2010;(6):3-7.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Sulzyc-Bielicka V, Kolodziejczyk L, Jaczewska S, et al. Prevalence of Cryptosporidium sp. in patients with colorectal cancer. Pol Przegl Chir. 2012;84(7):348-351. doi: 10.2478/v10035-012-0058-4.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Ubillos L, Freire T, Berriel E, et al. Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers. Int J Cancer. 2016;138(7):1719-1731. doi: 10.1002/ijc.29910.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Xiao X, Long W, Huang T, et al. Differences between the Intestinal Lumen Microbiota of Aberrant Crypt Foci (ACF)-Bearing and Non-bearing Rats. Dig Dis Sci. 2018;63(11):2923-2929. doi: 10.1007/s10620-018-5180-7.</mixed-citation></ref></ref-list></back></article>
